Director, Biostatistics and Statistical Programming
Xeris Pharmaceuticals
Robbie Huang, MS, is currently a Director of Biostatistics and Statistical Programming at Xeris Pharmaceuticals, Inc. Mr. Huang has spent 14 years working for contract research organizations (CROs) such as PPD and Syneos Health, where he played key roles in statistical analysis execution, project oversight, and team management. In 2019, Mr. Huang joined Xeris Pharmaceuticals and had been leading RECORLEV (for Cushing's Syndrome) clinical trials, which resulted in successful FDA approval. Currently, he leads various projects focused on ready-to-use glucagon and liquid formulation of levothyroxine (XP-8121 SC). Mr. Huang is passionate about using data analyses to make a positive impact on human health and well-being.